The Point of Care (PoC) molecular diagnostics market surpassed $ 1 billion in 2016 and is projected to grow by more than 9% from 2017 to 2024. The PoC molecular diagnostics market will maintain strong growth during the forecast period. As public awareness continues to rise, the incidence of infectious diseases is on the rise. Pre-disease testing to control its occurrence will prompt PoC molecules to diagnose growth in the 

market.

 

In an emergency of infectious diseases, rapid and accurate detection of pathogens is very important because inaccurate disease detection can lead to incorrect treatment, thereby increasing the risk of disease transmission. The point-of-care molecular diagnostics test allows timely detection of causative agents that can effectively control the disease.